BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25582170)

  • 1. Gene and cell therapy for pancreatic cancer.
    Singh HM; Ungerechts G; Tsimberidou AM
    Expert Opin Biol Ther; 2015 Apr; 15(4):505-16. PubMed ID: 25582170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.
    Rouanet M; Lebrin M; Gross F; Bournet B; Cordelier P; Buscail L
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hopes, Promises, and Future Directions of Gene and Cell Therapies in France.
    Cartier N; Cordelier P
    Hum Gene Ther; 2016 Feb; 27(2):96-7. PubMed ID: 26886830
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy for pancreatic cancer.
    Tseng JF; Mulligan RC
    Surg Oncol Clin N Am; 2002 Jul; 11(3):537-69. PubMed ID: 12487056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives.
    Hernandez-Alcoceba R; Sangro B; Berraondo P; Gonzalez-Aseguinolaza G; Prieto J
    Expert Opin Investig Drugs; 2013 Jul; 22(7):827-41. PubMed ID: 23594171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer).
    Yoshimura K; Olino K; Edil BH; Schulick RD; Oka M
    Surg Today; 2010 May; 40(5):404-10. PubMed ID: 20425541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of pancreatic cancer: how useful is it in clinical practice?
    Sakorafas GH; Smyrniotis V
    JOP; 2012 Jul; 13(4):332-7. PubMed ID: 22797383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging biological therapies for pancreatic carcinoma.
    Gilliam AD; Watson SA
    Eur J Surg Oncol; 2002 Jun; 28(4):370-8. PubMed ID: 12099644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Salvia R; Casciani F; Sereni E; Bassi C
    Presse Med; 2019 Mar; 48(3 Pt 2):e187-e197. PubMed ID: 30878338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology.
    Touchefeu Y; Harrington KJ; Galmiche JP; Vassaux G
    Aliment Pharmacol Ther; 2010 Oct; 32(8):953-68. PubMed ID: 20937041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of gene therapy in the treatment of pancreatic cancer.
    Kasuya H; Nomoto S; Nakao A
    Drugs Today (Barc); 2002 Jul; 38(7):457-64. PubMed ID: 12582463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for pancreatic cancer.
    Takeda S; Nakao A; Miyoshi K; Takagi H
    Semin Surg Oncol; 1998; 15(1):57-61. PubMed ID: 9671958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
    BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Promise of Gene Therapy for Pancreatic Cancer.
    Vassaux G; Angelova A; Baril P; Midoux P; Rommelaere J; Cordelier P
    Hum Gene Ther; 2016 Feb; 27(2):127-33. PubMed ID: 26603492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular landscape of pancreatic cancer: implications for current clinical trials.
    Heestand GM; Kurzrock R
    Oncotarget; 2015 Mar; 6(7):4553-61. PubMed ID: 25714017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
    Mosquera C; Maglic D; Zervos EE
    Cancer Genet; 2016 Dec; 209(12):567-581. PubMed ID: 27613577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Therapy for Pancreatic Diseases: Current Status.
    Kamimura K; Yokoo T; Terai S
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30384450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.